Breaking
Friday, June 19, 2026

Drug Approvals News

🇺🇸 FDA

FDA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–12 of 338 articles

Medium impact NewsJun 18, 2026

Adial Pharmaceuticals Completes Azora Merger, Expands Ulcerative Colitis Pipeline

FDA · 3 min

Michael Rivera
High impact NewsJun 16, 2026

FDA approves OTC Rextovy, broadening naloxone access for opioid overdose

FDA · opioid overdose · 6 min

Dr. Sarah Mitchell
High impact NewsJun 16, 2026

Lilly’s early JAK data raises myelofibrosis competition question

FDA · myelofibrosis · 6 min

Dr. Sarah Mitchell
Critical impact NewsJun 16, 2026

FDA authorizes emergency pet treatment for New World screwworm

FDA · New World screwworm · 4 min

Dr. Sarah Mitchell
High impact NewsJun 15, 2026

FDA guidance on sharing potential NDA patent information: what changes now

FDA · 4 min

Dr. Sarah Mitchell
Critical impact NewsJun 15, 2026

FDA expands Tzield to certain pediatric patients with recent Stage 3 T1D

FDA · diabetes · 5 min

Dr. Sarah Mitchell
High impact NewsJun 15, 2026

Medicare price rule could hit Keytruda and Opdivo subcutaneous launches

Medicare · cancer · 5 min

Dr. Sarah Mitchell
High impact NewsJun 15, 2026

FDA Approves Capivasertib for PTEN-Deficient Prostate Cancer

FDA · prostate cancer · 6 min

Dr. Sarah Mitchell
High impact NewsJun 15, 2026

FDA approves belzutifan plus pembrolizumab for adjuvant RCC

FDA · renal cell carcinoma · 6 min

Dr. Sarah Mitchell
High impact NewsJun 15, 2026

Prescription Drug Freight Fraud June 2026 report: what the record shows

EMA · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 13, 2026

Alembic Wins Tentative FDA Nod for First Generic Larotrectinib Capsules

FDA · NTRK fusion–positive solid tumors · 7 min

Dr. Sarah Mitchell
High impact NewsJun 12, 2026

FDA priority review advances belzutifan plus pembrolizumab in adjuvant RCC

FDA · adjuvant renal cell carcinoma · 6 min

Dr. Sarah Mitchell